(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(-0.11%) $0.926
(-0.10%) $10.83
(-0.15%) $0.791
(-0.09%) $92.49
@ $11.19
Issued: 13 Feb 2024 @ 10:58
Return: 28.60%
Live Chart Being Loaded With Signals
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer...
Stats | |
---|---|
Today's Volume | 348 542 |
Average Volume | 150 570 |
Market Cap | 37.20M |
EPS | $-3.42 ( 2024-03-27 ) |
Next earnings date | ( $-2.21 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.770 |
ATR14 | $0.153 (1.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-19 | Loewy Caroline M | Buy | 2 000 | Stock Option (Right to Buy) |
2024-02-19 | Bhatt Elizabeth | Buy | 2 000 | Stock Option (Right to Buy) |
2024-02-19 | Ehrlich Christopher B | Buy | 2 000 | Stock Option (Right to Buy) |
2024-02-19 | Klencke Barbara | Buy | 2 000 | Stock Option (Right to Buy) |
2024-02-19 | Harrington-smith Kristen | Buy | 2 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
47.89 |
Last 95 transactions |
Buy: 5 541 401 | Sell: 1 016 887 |
Volume Correlation
eFFECTOR Therapeutics, Correlation
10 Most Positive Correlations | |
---|---|
APOP | 0.91 |
FLGT | 0.875 |
PIII | 0.875 |
PRSR | 0.871 |
MAGS | 0.871 |
SOFIW | 0.867 |
CMLF | 0.867 |
LPTX | 0.864 |
AGCUU | 0.863 |
WKSP | 0.863 |
10 Most Negative Correlations | |
---|---|
ULTA | -0.855 |
IEP | -0.845 |
TNDM | -0.833 |
IART | -0.83 |
ASO | -0.829 |
CDAK | -0.828 |
IQ | -0.827 |
PAYS | -0.827 |
SBNYP | -0.817 |
PHCF | -0.815 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
eFFECTOR Therapeutics, Correlation - Currency/Commodity
eFFECTOR Therapeutics, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-111 000 (0.00 %) |
EPS: | $-16.37 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-30 000.00 (0.00 %) |
EPS: | $-3.42 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-26 000.00 (0.00 %) |
EPS: | $-3.36 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-27 000.00 (0.00 %) |
EPS: | $-4.37 |
Financial Reports:
No articles found.
eFFECTOR Therapeutics,
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 2clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators